InsidersTradesSigma
Follow the 삼진제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼진제약 has recorded 2 public disclosures. Market capitalisation: €222.9bn. The latest transaction was disclosed on 2 June 2026 (Other). Among the most active insiders: 최승주. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samjin Pharmaceutical 是一家韩国制药公司，专注于药品的研发和制造。该公司在 XKRX 市场上市。